Nursing care
Extravasation of Vesicants nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Extravasation of vesicants happens when a vesicant drug leaks from the vein into surrounding tissue, and the immediate response is to stop the infusion, leave the cannula in place, and aspirate residual drug through it. Removing the cannula first destroys the only access point left to withdraw the drug and administer an antidote, which is why sequence matters more than speed here.
The pathophysiology in one pass
A vesicant is any agent capable of causing blistering, tissue necrosis or sloughing if it escapes the vessel wall into subcutaneous tissue. Agents such as doxorubicin, vincristine and vinorelbine cause damage through direct cellular toxicity, and the injury continues to progress for hours to days after the leak, unlike a simple infiltration of a non-vesicant fluid.
The mechanism explains why vesicant extravasation is treated as a distinct emergency rather than a variant of routine IV infiltration. Vesicants bind to DNA or disrupt cell membranes in the tissue they contact, so the longer the drug sits against skin and subcutaneous structures, the deeper and wider the eventual tissue loss. Time and drug volume in the tissue are the two variables that determine outcome, which is why the nursing response is built entirely around limiting both.
Assessment findings that matter
Early signs include burning or stinging pain at the site, swelling, and blanching or a change in skin colour, often before any visible leakage is obvious. Absence of blood return on aspiration is a supporting sign but is not required to suspect extravasation, and a nurse should not wait for it before acting.
Distinguish extravasation from a flare reaction, which causes localised redness and itching without pain and typically resolves quickly with the infusion continuing under close observation. Confusing the two matters clinically: continuing a vesicant infusion through a true extravasation site converts a manageable event into extensive tissue necrosis.
What the exam asks about this
NCLEX-style items frequently test sequencing: which action comes first when a patient reports burning pain during a vesicant infusion. The correct first action is to stop the infusion, not to call the provider, not to apply a cold or warm compress, and not to remove the cannula.
A second common pattern presents a distractor answer of 'remove the IV catheter immediately' as the seemingly cautious choice. It is wrong precisely because it is intuitive; removing the cannula eliminates the route needed to aspirate the vesicant and to instil any antidote, so the exam is testing whether you understand the rationale rather than reacting on instinct.
Nursing interventions in priority order
Stop the infusion immediately but do not disconnect the tubing or remove the cannula. Aspirate as much residual drug as possible through the existing cannula using a small syringe, then disconnect the infusion set while leaving the cannula in place.
Notify the prescriber and pharmacy to determine whether a specific antidote is indicated for that vesicant, since some agents such as anthracyclines have a defined antidote while others do not. Elevate the limb, apply the temperature-specific compress recommended for that drug, either warm or cold depending on the agent, mark and photograph the site if your facility protocol requires it, and document the estimated extravasated volume, timing, and all actions taken.
Medications and monitoring
Dexrazoxane is the specific antidote for anthracycline extravasation and must be started within six hours for maximum effect; hyaluronidase is used for certain plant alkaloid vesicants like vincristine, injected in a clock-pattern around the site. Match the antidote to the drug class rather than applying a generic protocol to every vesicant.
Ongoing monitoring focuses on the evolving appearance of the site over the following 24 to 48 hours, since tissue damage from vesicants often worsens before it stabilises. Pain, blistering, and skin colour changes should be reassessed and documented at intervals set by facility protocol, with photography used to track progression objectively.
When to escalate
Escalate to the oncology or wound care team immediately if blistering, skin breakdown, or increasing pain develops despite initial management, or if the extravasated volume was large or the agent is one with a high necrotic potential such as an anthracycline.
Plastic surgery referral is warranted when tissue necrosis is evident or the site fails to improve within the expected window, since vesicant injuries can progress to full-thickness skin loss requiring debridement or grafting. Any suspicion of compartment syndrome, marked by disproportionate pain, tense swelling, or diminished distal pulses, requires urgent surgical assessment rather than continued conservative monitoring.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Should you remove the IV cannula if a vesicant extravasates?
No. Leave the cannula in place and aspirate through it first, because it is the only access point to withdraw residual drug or instil an antidote. Removing it first eliminates that option.
What is the first nursing action when extravasation is suspected?
Stop the infusion immediately. Do not disconnect the tubing or remove the cannula until you have attempted to aspirate the residual drug through the existing line.
How is extravasation different from a flare reaction?
A flare reaction causes localised redness and itching without significant pain and usually resolves while the infusion continues. Extravasation causes burning pain and swelling from drug leaking into tissue and requires the infusion to be stopped immediately.
What antidote is used for anthracycline extravasation?
Dexrazoxane is the specific antidote for anthracycline vesicants like doxorubicin, and it is most effective when started within six hours of the extravasation event.
When should a vesicant extravasation be escalated to a specialist?
Escalate to oncology or wound care if blistering or skin breakdown appears, or to plastic surgery if tissue necrosis develops or the site fails to improve, since these injuries can progress to full-thickness skin loss.
More on pharmacology
Guides on this